CN102335300A - Stone decomposing and discharging medicament - Google Patents
Stone decomposing and discharging medicament Download PDFInfo
- Publication number
- CN102335300A CN102335300A CN2010102346307A CN201010234630A CN102335300A CN 102335300 A CN102335300 A CN 102335300A CN 2010102346307 A CN2010102346307 A CN 2010102346307A CN 201010234630 A CN201010234630 A CN 201010234630A CN 102335300 A CN102335300 A CN 102335300A
- Authority
- CN
- China
- Prior art keywords
- calculus
- medicine
- medicament
- medicinal liquid
- leached
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 238000007599 discharging Methods 0.000 title abstract description 6
- 239000004575 stone Substances 0.000 title abstract description 4
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 5
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 206010007027 Calculus urinary Diseases 0.000 claims description 13
- 208000009911 Urinary Calculi Diseases 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 4
- 241000600871 Euryale <brittle star> Species 0.000 claims description 3
- 235000006487 Euryale ferox Nutrition 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 2
- 208000031868 Calculus ureteric Diseases 0.000 abstract description 12
- 208000000014 Ureteral Calculi Diseases 0.000 abstract description 12
- 208000006568 Urinary Bladder Calculi Diseases 0.000 abstract description 11
- 208000000913 Kidney Calculi Diseases 0.000 abstract description 10
- 206010029148 Nephrolithiasis Diseases 0.000 abstract description 10
- 201000001883 cholelithiasis Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 238000007796 conventional method Methods 0.000 abstract description 3
- 241000722953 Akebia Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 208000004845 Cholecystolithiasis Diseases 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000183914 Dianthus superbus Species 0.000 abstract 1
- 235000013535 Dianthus superbus Nutrition 0.000 abstract 1
- 244000268590 Euryale ferox Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 241000025505 Pyrrosia Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000000626 ureter Anatomy 0.000 description 3
- 210000001635 urinary tract Anatomy 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000001130 gallstones Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020524 Hydronephrosis Diseases 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 208000015924 Lithiasis Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a stone decomposing and discharging medicament, which belongs to the technical field of medicaments for treating renal calculus, vesical calculus, ureteral calculus and cholelithiasis cholecystolithiasis. In the medicament, rhizoma alismatis, dianthus superbus, akebia stem, gorgon euryale seed, talcum powder, pyrrosia leaf, liquoric root, salt-fried golden cypress, chrysanthemum, prepared rhizome of rehmannia, heterophylly falsestarwort root, honeysuckle, medlar and Chinese magnoliavine fruit are used as raw materials and are prepared into liquid medicine in proportion according to different characteristics of each traditional Chinese medicine by the conventional method. The medicament has a unique formula, an obvious treatment effect and 100 percent of total effectiveness ratio.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of medicine of treating renal calculus, vesical calculus, ureteral calculus, is a kind of fossil urinary calculus removing Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
The background technology calculus, of a great variety.Surgical clinical is urinary stone and cholelithiasis very commonly; Kidney, ureter or bladder borough chief have gone up " stone ", not only can cause pain, hematuria, if also can cause urinary tract infection " stone " long-term blockage urinary tract; Cause hydronephrosis, renal function all can suffer damage.Lithangiuria is one of modal urological diseases.The male is more than the women, and about 4~5: 1.Formation mechanism is not illustrated fully, and multiple theory is arranged, and relapse rate is high.Most calculus still there is not very good prevention method. the urinary calculus morbidity has provincialism, is more common on the south the Changjiang river in China.The north is rare relatively, and in the last thirty years, urinary tract in China (kidney, ureter) calculus sickness rate significantly improves, and lower urinary tract (bladder) calculus is rare day by day.In the vesical calculus, the constitutional calculus obviously is less than the Secondary cases calculus.Over past ten years, the Therapeutic Method of lithangiuria has had and has developed rapidly, and about 90% lithangiuria can no longer adopt traditional open surgery treatment.Treating lithangiuria will consider from two aspects, the one, and treatment protopathy such as metabolism disorder are infected or already present anatomical factors; Be that the complication of handling calculus is promptly blocked, infected on the other hand, the most simple and effectively great quantity of water drinking, dilute urine can delay the urinary calculi growth and prevent that urinary calculi from sending out again, has can promote drain more than when the infection great quantity of water drinking; Change urine pH and also can prevent recurrence of hepatolithiasis, cystine more is soluble in pH in the urine more than 7.5, but soda and sodium citrate alkalized urine, oral uric acid and 2 of reducing of allopurinol, so the generation of the two hydroxyl adenine of 8-is effective to controlling such recurrence of hepatolithiasis.At present, for ureteral calculus and cholelithiasis, acupuncture and treatment by Chinese herbs effect are all better, block or infect heavier case and calculus bigger, when the method for using can not be discharged calculus, still adopt surgical calculus removing, the patient suffering is big.
Summary of the invention the purpose of this invention is to provide a kind of with clearing away heat and promoting diuresis, treating stranguria, fossil urinary calculus removing medicine that urolith-discharging and urolith-eliminating is the rule of treatment, to overcome the deficiency of prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's traditional medicine calculus; With reference to modern pharmacological research; Therefrom filter out the natural Chinese medicinal herb of clearing away heat and promoting diuresis, treating stranguria, urolith-discharging and urolith-eliminating, press the Chinese medical theory prescription, the effect that makes its performance remove calculus.
Medicine of the present invention is the medicament of being processed by the following weight proportion raw material
Rhizoma Alismatis 20g Herba Dianthi 25g Caulis Akebiae 23g, Semen Euryales 15g Pulvis Talci 28g Folium Pyrrosiae 12g Radix Glycyrrhizae 11g
Cortex Phellodendri Amurensis (parched with salt) 19g Flos Chrysanthemi 20g Radix Rehmanniae Preparata 30g Radix Pseudostellariae 10g Flos Lonicerae 20g Fructus Lycii 15g
Fructus Schisandrae Chinensis 6g
Above-mentioned each component is processed medicine oral liquid of the present invention by conventional method:
Said medicine is put into marmite or stainless-steel pan, add water by 1: 2 of medicine gross weight proportioning, slow fire boiling was boiled back 20 minutes; Medicinal liquid is leached, and 1: 1 by medicine gross weight proportioning adds the decoction of hydrology fire again, boils back 20 minutes; Medicinal liquid is leached, merge medicinal liquid twice, bottling.
Medicine of the present invention is a Chinese medicine preparation, according to the theory of Chinese medical science prescription, selects that medicine is reasonable, dosage form is advanced, has the effect of clearing away heat and promoting diuresis, treating stranguria, urolith-discharging and urolith-eliminating; Control the damp and hot urine stranguria shape that causes, waist, abdominal part pain, it is not smooth to urinate, with hematuria, renal calculus, vesical calculus, ureteral calculus and cholelithiasis.Herb liquid of the present invention, evident in efficacy through clinical observation patient for many years, the patient of renal calculus, vesical calculus, ureteral calculus and cholelithiasis there is remarkable result.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, to select natural plant for use be raw material in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment calculosis of the medicine of respectively distinguishing the flavor of, and no chemicals is harmless to human non-toxic, has no side effect, and is safe and reliable.
2, slow fire of the present invention is fried in shallow oil water and is concentrated, and effective ingredient scatters and disappears few, and curative effect is high, and is cheap, taking convenience, no any discomfort disease.
3, medicine of the present invention is obvious to renal calculus, vesical calculus, ureteral calculus and cholelithiasis curative effect.
4, clinical drug of the present invention is observed, the medicine of instead other treatment renal calculus, vesical calculus, ureteral calculus and cholelithiasis.
For showing the therapeutic effect of medicine of the present invention to renal calculus, vesical calculus, ureteral calculus and cholelithiasis; The present invention is through the clinical observation of 2000 routine renal calculuss, vesical calculus, ureteral calculus and gallstone patients system; And select medical history, the state of an illness, age, sex and renal calculus, vesical calculus, ureteral calculus and gallstone patients 100 examples suitable to organize wherein male 1800 examples, women 200 examples as a comparison with traditional therapy; 25~60 years old age, course of disease May~2 year.Test group: the conventional medicine of stopping using, use medicine of the present invention; Matched group: take conventional medicine.Observation period is 3 months, checks after half a year, and calculus disappears and to be that produce effects, calculus diminish to effectively, and calculus reduces not obvious for invalid.
Method for using: a 100g, one 2 times, one day medicine of every take, intermittently medication again in a day, 15 days is a course of treatment.Clinical test results is seen table 1.
Table 1: use medicine of the present invention and take the observation of curative effect of conventional medicine to the calculus patient
Group | Case load | Produce effects (routine number) | Effectively (routine number) | Invalid (routine number) | Total effective rate (%) |
Test group | 2000 | 1400 | 600 | 0 | 100 |
Matched group | 100 | 0 | 70 | 30 | 70.0 |
T | 2.40 | 5.20 | 2.30 | 3.90 | |
P | <0.05 | <0.05 | <0.05 | <0.05 | <0.05 |
Can find out that from table 1 medicine of the present invention is obtained 1400 examples that have of significant curative effect to 2000 routine calculus patients, accounts for 70.0%; That takes a turn for the better has 600 examples, accounts for 30.0%; Total effective rate reaches 100%.
The specific embodiment
Take by weighing raw material by following proportioning:
Rhizoma Alismatis 20g Herba Dianthi 25g Caulis Akebiae 23g, Semen Euryales 15g Pulvis Talci 28g Folium Pyrrosiae 12g Radix Glycyrrhizae 11g
Cortex Phellodendri Amurensis (parched with salt) 19g Flos Chrysanthemi 20g Radix Rehmanniae Preparata 30g Radix Pseudostellariae 10g Flos Lonicerae 20g Fructus Lycii 15g
Fructus Schisandrae Chinensis 6g
Said medicine is put into marmite or stainless-steel pan, add water by 1: 2 of medicine gross weight proportioning, slow fire boiling was boiled back 20 minutes; Medicinal liquid is leached, and 1: 1 by medicine gross weight proportioning adds the decoction of hydrology fire again, boils back 20 minutes; Medicinal liquid is leached, merge medicinal liquid twice, bottling gets final product.
Cortex Phellodendri Amurensis (parched with salt) wherein adds an amount of saturated aqueous common salt by Cortex Phellodendri and forms by the conventional method process of preparing Chinese medicine.
Model case
1, Yao Xingai, the woman 45 years old, suffers from ureteral calculus B ultrasonic data 2 * 35mm; Take medicine of the present invention after course of treatment, calculus 1 * 2mm; After continuing to take two courses of treatment, row is 1 * 2mm calculus down, and B ultrasonic shows that ureter has only the calculus of 2 * 3mm, continue to take three courses of treatment after, the whole emptyings of calculus.
2. Wang Xi is right, the man, 25 years old, the multiple calculus of right kidney, the preceding 29 * 13mm that takes medicine, take a course of treatment medicine after B ultrasonic show that 22 * 13mm data obviously reduce, with the whole emptyings of multiple calculus after 3 courses of treatment.
3. Liu is precious, the woman, and 51 years old, suffer from cholelithiasis, course of treatment calculus emptying is obeyed a course of treatment again and is consolidated.
Medicine of the present invention is an oral medicine, small number of patients with after untoward reaction is arranged, phenomenon can appear vomitting.
Taboo: wine, Aqua Folium Camelliae sinensis.
Points for attention: the careful usefulness of taste void person and anemia of pregnant woman, period in a medicine should drink water more, appropriate exercise.
Medicine clearing away heat and promoting diuresis of the present invention, treating stranguria, urolith-discharging and urolith-eliminating, control the damp and hot urine stranguria shape that causes, waist, abdominal part pain, urinate smooth, with hematuria, renal calculus, vesical calculus, ureteral calculus.
Claims (1)
1. a fossil urinary calculus removing medicine is characterized in that being processed by following raw materials by weight proportions: Rhizoma Alismatis 20g Herba Dianthi 25g Caulis Akebiae 23g, Semen Euryales 15g Pulvis Talci 28g Folium Pyrrosiae 12g Radix Glycyrrhizae 11g Cortex Phellodendri Amurensis (parched with salt) 19g Flos Chrysanthemi 20g Radix Rehmanniae Preparata 30g Radix Pseudostellariae 10g Flos Lonicerae 20g Fructus Lycii 15g Fructus Schisandrae Chinensis 6g; Said medicine is put into marmite or stainless-steel pan, add water by 1: 2 of medicine gross weight proportioning, slow fire boiling was boiled back 20 minutes; Medicinal liquid is leached, and 1: 1 by medicine gross weight proportioning adds the decoction of hydrology fire again, boils back 20 minutes; Medicinal liquid is leached, merge medicinal liquid twice, bottling gets final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102346307A CN102335300B (en) | 2010-07-23 | 2010-07-23 | Stone decomposing and discharging medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102346307A CN102335300B (en) | 2010-07-23 | 2010-07-23 | Stone decomposing and discharging medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102335300A true CN102335300A (en) | 2012-02-01 |
CN102335300B CN102335300B (en) | 2012-10-31 |
Family
ID=45511400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102346307A Expired - Fee Related CN102335300B (en) | 2010-07-23 | 2010-07-23 | Stone decomposing and discharging medicament |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102335300B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697866A (en) * | 2012-06-26 | 2012-10-03 | 南京同仁堂药业有限责任公司 | Ultrasonic extraction process for particles for removing urinary calculus |
CN102861288A (en) * | 2012-09-04 | 2013-01-09 | 刘长灵 | Traditional Chinese medicine composite for treating kidney stone |
CN104337872A (en) * | 2014-11-11 | 2015-02-11 | 黄雷 | Chinese medicinal formula for treating lithangiuria |
CN104857380A (en) * | 2015-06-01 | 2015-08-26 | 步向阳 | Traditional Chinese medicine for adjuvant therapy in complicated gallstone surgery and preparation method of traditional Chinese medicine |
-
2010
- 2010-07-23 CN CN2010102346307A patent/CN102335300B/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
唐仕勇等: "尿石症治疗近况", 《黑龙江中医药》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697866A (en) * | 2012-06-26 | 2012-10-03 | 南京同仁堂药业有限责任公司 | Ultrasonic extraction process for particles for removing urinary calculus |
CN102861288A (en) * | 2012-09-04 | 2013-01-09 | 刘长灵 | Traditional Chinese medicine composite for treating kidney stone |
CN104337872A (en) * | 2014-11-11 | 2015-02-11 | 黄雷 | Chinese medicinal formula for treating lithangiuria |
CN104857380A (en) * | 2015-06-01 | 2015-08-26 | 步向阳 | Traditional Chinese medicine for adjuvant therapy in complicated gallstone surgery and preparation method of traditional Chinese medicine |
Also Published As
Publication number | Publication date |
---|---|
CN102335300B (en) | 2012-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099959B (en) | Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof | |
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
CN102600417B (en) | Traditional Chinese medicine composition for treating rumen bloat in cattle and sheep | |
CN102335300B (en) | Stone decomposing and discharging medicament | |
CN103041256B (en) | Chinese herb preparation for curing recurrent respiratory tract infection of children | |
CN102526670A (en) | Traditional Chinese medicinal composition for treating cholecystitis and preparation method thereof | |
CN101085328A (en) | Oral administration traditional Chinese medicine composition for curing chronic gastritis | |
CN103041257B (en) | Chinese materia medica preparation for curing high fever and respiratory tract infection of children | |
CN103041255B (en) | Chinese materia medica preparation for curing swollen sore throat and respiratory tract infection of children | |
CN103041028B (en) | Traditional Chinese medicine composition for treating acne | |
CN104758900A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
CN101897733B (en) | Drug for curing bladder stone and preparation method thereof | |
CN101991751A (en) | Medicament for treating tumors | |
CN105327182A (en) | Medicine for treating child pertussis and preparation method thereof | |
CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
CN104771637A (en) | Cholagogic and lithagogue agent for treating gallstone and preparation method thereof | |
CN103877484A (en) | Traditional Chinese medicine oral liquid for treating oral liquid | |
CN101380414B (en) | Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof | |
CN103041258B (en) | Chinese materia medica preparation for curing respiratory tract infection with poor appetite of children | |
CN101411831B (en) | Medicament for treating low fever | |
CN104771528A (en) | Traditional Chinese medicine composition for treating urinary calculi | |
CN104173952A (en) | Traditional Chinese medicine composition for treating benign ovarian tumor | |
CN104367862A (en) | Traditional Chinese medicinal composition for treating urethral calculus | |
CN104740396A (en) | Traditional Chinese medicine for treating kidney stones and preparation method of traditional Chinese medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121031 |